Old Web
English
Sign In
Acemap
>
authorDetail
>
Ahmed Shelbaya
Ahmed Shelbaya
Columbia University
Medicine
Biosimilar
Internal medicine
Oncology
Health care
4
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Greater uptake, an alternative reimbursement methodology needed to realize cost-saving potential of oncology biosimilars in the United States.
2021
Journal of managed care & specialty pharmacy
Jingyan Yang
Jennifer Carioto
Bruce Pyenson
Rebecca Smith
Nathaniel Jacobson
Sean Pittinger
Ahmed Shelbaya
Show All
Source
Cite
Save
Citations (0)
Real-world use and acceptance of biosimilar monoclonal antibodies of rituximab in oncology practice in the USA.
2021
Future Oncology
Ahmed Shelbaya
John M. Kelton
Jeffrey Thompson
Jose Mj Alvir
Martine C. Maculaitis
Jingyan Yang
Show All
Source
Cite
Save
Citations (0)
Evolving Perceptions, Utilization, and Real-World Implementation Experiences of Oncology Monoclonal Antibody Biosimilars in the USA: Perspectives from Both Payers and Physicians
2021
BioDrugs
Jingyan Yang
Kelly Blinzler
Joshua Lankin
Sapna Vijayakumar
Martine C. Maculaitis
Ahmed Shelbaya
Show All
Source
Cite
Save
Citations (0)
A review of the health economic and resource utilization literature for the use of tigecycline treatment of complicated intra-abdominal infections
2015
Medical research archives
Bruce Wang
Y Chen
Wesley Furnback
P. Dong
Ahmed Shelbaya
Show All
Source
Cite
Save
Citations (0)
1